Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionvoltage-gated monoatomic anion channel activity

GPR89B CLCNKA CLCNKB GPR89A

6.75e-06171504GO:0008308
GeneOntologyCellularComponentcytoplasmic vesicle membrane

GPR89B EEF1AKMT4-ECE2 MGAM DMXL2 ZFYVE16 ABCA13 SEC24A TICAM1 SLC44A2 MPEG1 LAMP2 APOB ASB14 GPR161 WASH6P GBP5 ABCA5 PKD1 SORCS2 GPR89A UNC13C NOSTRIN

1.47e-04130714922GO:0030659
GeneOntologyCellularComponentRAVE complex

DMXL2 DMXL1

1.51e-0431492GO:0043291
GeneOntologyCellularComponentvesicle membrane

GPR89B EEF1AKMT4-ECE2 MGAM DMXL2 ZFYVE16 ABCA13 SEC24A TICAM1 SLC44A2 MPEG1 LAMP2 APOB ASB14 GPR161 WASH6P GBP5 ABCA5 PKD1 SORCS2 GPR89A UNC13C NOSTRIN

1.79e-04132514922GO:0012506
HumanPhenoAbnormal glomerular filtration rate

CASR CLCNKA CLCNKB PKD1 SLC37A4

1.55e-0529585HP:0012212
HumanPhenoDecreased glomerular filtration rate

CASR CLCNKA CLCNKB PKD1 SLC37A4

1.55e-0529585HP:0012213
DomainRav1p_C

DMXL2 DMXL1

5.82e-0521432IPR022033
DomainRav1p_C

DMXL2 DMXL1

5.82e-0521432PF12234
DomainCl_channel-K

CLCNKA CLCNKB

5.82e-0521432IPR002250
DomainABC_A

ABCA13 ABCA8 ABCA5

9.19e-05121433IPR026082
DomainVWF_A

COL12A1 VWF SEC24A MATN1 ITIH2 ANAPC1

1.13e-04991436IPR002035
Domain-

COL12A1 VWF SEC24A MATN1 ITIH2

2.59e-047414353.40.50.410
DomainHJURP_C

MEF2A MEF2C

3.46e-0441432IPR022102
DomainMADS_MEF2-like

MEF2A MEF2C

3.46e-0441432IPR033896
DomainPC1

PKD1L3 PKD1

3.46e-0441432IPR000434
DomainHJURP_C

MEF2A MEF2C

3.46e-0441432PF12347
DomainMADS_BOX_1

MEF2A MEF2C

8.56e-0461432PS00350
DomainMADS

MEF2A MEF2C

8.56e-0461432SM00432
DomainHydantoinase/dihydroPyrase

DPYSL3 CRMP1

8.56e-0461432IPR011778
DomainSRF-TF

MEF2A MEF2C

8.56e-0461432PF00319
DomainMADS_BOX_2

MEF2A MEF2C

8.56e-0461432PS50066
DomainVWA

COL12A1 VWF MATN1 ITIH2

8.89e-04561434PF00092
DomainTIR_dom

TICAM1 TLR5 IL17RD

8.93e-04251433IPR000157
DomainPKD

PKD1 SORCS2

1.19e-0371432PF00801
DomainTF_MADSbox

MEF2A MEF2C

1.19e-0371432IPR002100
Domain-

DPYSL3 CRMP1

1.58e-03814322.30.40.10
DomainLAMININ_IVA

LAMA3 LAMC1

1.58e-0381432PS51115
DomainLaminin_B

LAMA3 LAMC1

1.58e-0381432PF00052
DomainLamB

LAMA3 LAMC1

1.58e-0381432SM00281
DomainLaminin_IV

LAMA3 LAMC1

1.58e-0381432IPR000034
DomainCl-channel_core

CLCNKA CLCNKB

2.02e-0391432IPR014743
Domain-

CLCNKA CLCNKB

2.02e-03914321.10.3080.10
DomainVoltage_CLC

CLCNKA CLCNKB

2.02e-0391432PF00654
DomainCl-channel_volt-gated

CLCNKA CLCNKB

2.02e-0391432IPR001807
DomainPKD/Chitinase_dom

PKD1 SORCS2

2.02e-0391432IPR022409
DomainPKD

PKD1 SORCS2

2.02e-0391432SM00089
DomainP-loop_NTPase

SPAST KIF27 ABCA13 NOA1 MSH2 FANCM ABCA8 NLRC4 RRAGC EEF2 GBP4 GBP5 ABCA5 HFM1 KIF5B

2.17e-0384814315IPR027417
DomainLRR_TYP

LRWD1 IGSF10 TLR5 LRRTM2 PKD1 SLITRK6

2.44e-031771436SM00369
DomainLeu-rich_rpt_typical-subtyp

LRWD1 IGSF10 TLR5 LRRTM2 PKD1 SLITRK6

2.44e-031771436IPR003591
DomainAmidohydro_1

DPYSL3 CRMP1

2.52e-03101432PF01979
DomainGBP_C

GBP4 GBP5

2.52e-03101432PF02841
DomainMetal-dep_hydrolase_composite

DPYSL3 CRMP1

2.52e-03101432IPR011059
Domain-

RGPD1 GOLGA4

2.52e-031014321.10.220.60
DomainGrip

RGPD1 GOLGA4

3.06e-03111432SM00755
DomainG_GB1_RHD3_dom

GBP4 GBP5

3.06e-03111432IPR030386
DomainGRIP

RGPD1 GOLGA4

3.06e-03111432PF01465
DomainGuanylate-bd_N

GBP4 GBP5

3.06e-03111432IPR015894
DomainPKD

PKD1 SORCS2

3.06e-03111432PS50093
DomainPKD_dom

PKD1 SORCS2

3.06e-03111432IPR000601
DomainPKD_channel

PKD1L3 PKD1

3.06e-03111432PF08016
DomainGuanylate-bd_C

GBP4 GBP5

3.06e-03111432IPR003191
DomainGBP

GBP4 GBP5

3.06e-03111432PF02263
DomainAmidohydro-rel

DPYSL3 CRMP1

3.06e-03111432IPR006680
DomainPKD1_2_channel

PKD1L3 PKD1

3.06e-03111432IPR013122
Domain-

PKD1 SORCS2

3.06e-031114322.60.40.670
DomainG_GB1_RHD3

GBP4 GBP5

3.06e-03111432PS51715
DomainTPR

TTC28 RGPD1 TTC27 TEX11 CDC27

3.16e-031291435SM00028
DomainTPR_repeat

TTC28 RGPD1 TTC27 TEX11 CDC27

3.60e-031331435IPR019734
DomainVWFA

COL12A1 VWF MATN1 ITIH2

3.63e-03821434PS50234
DomainGRIP_dom

RGPD1 GOLGA4

3.65e-03121432IPR000237
DomainGRIP

RGPD1 GOLGA4

3.65e-03121432PS50913
DomainVWA

COL12A1 VWF MATN1 ITIH2

3.96e-03841434SM00327
Domain-

SPAST ABCA13 NOA1 MSH2 FANCM ABCA8 NLRC4 RRAGC EEF2 GBP4 GBP5 ABCA5 HFM1

4.84e-03746143133.40.50.300
DomainCys-rich_flank_reg_C

IGSF10 TLR5 PKD1 SLITRK6

5.06e-03901434IPR000483
DomainLRRCT

IGSF10 TLR5 PKD1 SLITRK6

5.06e-03901434SM00082
DomainABC_tran

ABCA13 ABCA8 ABCA5

5.91e-03481433PF00005
DomainABC_TRANSPORTER_2

ABCA13 ABCA8 ABCA5

5.91e-03481433PS50893
DomainABC_TRANSPORTER_1

ABCA13 ABCA8 ABCA5

6.26e-03491433PS00211
DomainCBS

CLCNKA CLCNKB

6.51e-03161432SM00116
DomainGRAM

TBC1D9 GRAMD2A

6.51e-03161432SM00568
DomainLaminin_N

LAMA3 LAMC1

6.51e-03161432IPR008211
DomainLamNT

LAMA3 LAMC1

6.51e-03161432SM00136
DomainLAMININ_NTER

LAMA3 LAMC1

6.51e-03161432PS51117
DomainLaminin_N

LAMA3 LAMC1

6.51e-03161432PF00055
DomainABC_transporter-like

ABCA13 ABCA8 ABCA5

6.62e-03501433IPR003439
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

HEXB PIGN GPR89B DPYSL3 COL12A1 LEMD2 LAMC1 LAMP2 LBR DMXL1 IGSF10 EEF2 NEGR1 FANCI LTN1 ADAM17 KIF5B TRIM13 SLC37A4 PLXNA1

2.85e-0712011512035696571
Pubmed

Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis.

VWF MEF2A MEF2C

3.20e-07415138817457
Pubmed

Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.

FANCM BRCA2 FANCI

3.20e-074151319737859
Pubmed

Platr4 is an early embryonic lncRNA that exerts its function downstream on cardiogenic mesodermal lineage commitment.

VWF ITGA8 LAMC1 MEF2C

3.30e-0714151436347239
Pubmed

Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.

MYF5 MEF2A MEF2C

2.77e-06715138026334
Pubmed

Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2.

MYF5 MEF2A MEF2C

2.77e-06715139418854
Pubmed

The human plasma proteome: a nonredundant list developed by combination of four separate sources.

TBXAS1 VWF BCHE APOB F8 ITIH2 GOLGA4

8.28e-06165151714718574
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

DMXL2 ZFYVE16 VPS8 LBR DMXL1 RRAGC GPR89A ADAM17 TRIM13 PLXNA1 GOLGA4

1.38e-055041511134432599
Pubmed

Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling.

NLRC4 GBP4 GBP5

1.72e-0512151335906252
Pubmed

Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1.

MYF5 MEF2A MEF2C

1.72e-0512151316424906
Pubmed

Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII.

VWF F8

1.87e-052151215731176
Pubmed

Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.

MEF2A MEF2C

1.87e-052151216469744
Pubmed

Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.

MEF2A MEF2C

1.87e-052151225336633
Pubmed

The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.

CLCNKA CLCNKB

1.87e-052151227335120
Pubmed

A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.

VWF F8

1.87e-052151238320121
Pubmed

Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.

VWF F8

1.87e-052151233221577
Pubmed

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor.

VWF F8

1.87e-052151236240294
Pubmed

Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

VWF F8

1.87e-052151219110358
Pubmed

Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization.

CLCNKA CLCNKB

1.87e-05215128812470
Pubmed

Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.

VWF F8

1.87e-052151223690449
Pubmed

Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rates.

VWF SLC44A2

1.87e-052151233556175
Pubmed

Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.

VWF F8

1.87e-052151222219226
Pubmed

Associations between CLCNKA_B tag SNPs with essential hypertension and interactions between genetic and environmental factors in an island population in China.

CLCNKA CLCNKB

1.87e-052151225919862
Pubmed

von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.

VWF F8

1.87e-052151226635035
Pubmed

The role of VWF in the immunogenicity of FVIII.

VWF F8

1.87e-052151218549909
Pubmed

The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.

VWF F8

1.87e-05215129218428
Pubmed

The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.

VWF F8

1.87e-05215127756647
Pubmed

Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.

VWF F8

1.87e-052151218535282
Pubmed

Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus.

VWF F8

1.87e-052151220624989
Pubmed

Association of the factor VIII light chain with von Willebrand factor.

VWF F8

1.87e-05215123134349
Pubmed

The influence of von Willebrand factor on factor VIII activity measurements.

VWF F8

1.87e-052151218983499
Pubmed

Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium.

VWF F8

1.87e-052151214517489
Pubmed

Surface-exposed hemophilic mutations across the factor VIII C2 domain have variable effects on stability and binding activities.

VWF F8

1.87e-052151215471879
Pubmed

The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.

VWF F8

1.87e-05215128562925
Pubmed

Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.

CLCNKA CLCNKB

1.87e-052151238069401
Pubmed

GPHR-dependent functions of the Golgi apparatus are essential for the formation of lamellar granules and the skin barrier.

GPR89B GPR89A

1.87e-052151222572823
Pubmed

Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages.

NLRC4 TLR5

1.87e-052151216648852
Pubmed

Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.

MEF2A XIRP2

1.87e-052151220093629
Pubmed

Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins.

MEF2A MEF2C

1.87e-052151221741404
Pubmed

von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.

VWF F8

1.87e-052151220492463
Pubmed

Myomaxin is a novel transcriptional target of MEF2A that encodes a Xin-related alpha-actinin-interacting protein.

MEF2A XIRP2

1.87e-052151217046827
Pubmed

Solution structure of the major factor VIII binding region on von Willebrand factor.

VWF F8

1.87e-052151224700780
Pubmed

Human exonuclease I interacts with the mismatch repair protein hMSH2.

MSH2 EXO1

1.87e-05215129788596
Pubmed

Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies.

VWF F8

1.87e-052151221940821
Pubmed

Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings.

VWF F8

1.87e-052151226473492
Pubmed

A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.

CLCNKA CLCNKB

1.87e-052151220805576
Pubmed

Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment.

VWF F8

1.87e-052151220194895
Pubmed

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.

VWF F8

1.87e-052151223349392
Pubmed

NLRC4 and TLR5 each contribute to host defense in respiratory melioidosis.

NLRC4 TLR5

1.87e-052151225232720
Pubmed

Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.

MEF2A MEF2C

1.87e-052151217611778
Pubmed

Interaction between VWF and FVIII in treating VWD.

VWF F8

1.87e-052151225605439
Pubmed

Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms.

ASXL1 JAK2

1.87e-052151238340948
Pubmed

von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.

VWF F8

1.87e-052151237756521
Pubmed

GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus.

GPR89B GPR89A

1.87e-052151218794847
Pubmed

Salt wasting and deafness resulting from mutations in two chloride channels.

CLCNKA CLCNKB

1.87e-052151215044642
Pubmed

ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.

ASXL1 JAK2

1.87e-052151227640403
Pubmed

Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies.

VWF F8

1.87e-052151217958741
Pubmed

Von Willebrand factor processing.

VWF F8

1.87e-052151228139814
Pubmed

Swimming Motility Mediates the Formation of Neutrophil Extracellular Traps Induced by Flagellated Pseudomonas aeruginosa.

NLRC4 TLR5

1.87e-052151227855208
Pubmed

Two highly homologous members of the ClC chloride channel family in both rat and human kidney.

CLCNKA CLCNKB

1.87e-05215128041726
Pubmed

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis.

VWF F8

1.87e-052151232032127
Pubmed

Anti-heavy-chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor.

VWF F8

1.87e-052151212958606
Pubmed

ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden.

ASXL1 JAK2

1.87e-052151233046688
Pubmed

Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner.

VWF F8

1.87e-052151237720212
Pubmed

A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.

CLCNKA CLCNKB

1.87e-052151218648499
Pubmed

Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.

VWF F8

1.87e-052151223168412
Pubmed

Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.

VWF F8

1.87e-052151232189311
Pubmed

The dermal-epidermal junction of human skin contains a novel laminin variant.

LAMA3 LAMC1

1.87e-05215121383241
Pubmed

Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney.

CLCNKA CLCNKB

1.87e-05215128544406
Pubmed

CRMP1 and CRMP4 are required for proper orientation of dendrites of cerebral pyramidal neurons in the developing mouse brain.

DPYSL3 CRMP1

1.87e-052151227836492
Pubmed

Sublingual flagellin protects against acute pneumococcal pneumonia in a TLR5-dependent and NLRC4-independent fashion.

NLRC4 TLR5

1.87e-052151227546231
Pubmed

Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia.

JAK2 GOLGA4

1.87e-052151234697799
Pubmed

Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor.

VWF F8

1.87e-052151232544272
Pubmed

Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization.

DPYSL3 CRMP1

1.87e-052151212814366
Pubmed

Redundant and cooperative interactions between TLR5 and NLRC4 in protective lung mucosal immunity against Pseudomonas aeruginosa.

NLRC4 TLR5

1.87e-052151225402425
Pubmed

Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions.

VWF F8

1.87e-052151215459008
Pubmed

A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.

VWF F8

1.87e-052151223335368
Pubmed

High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.

VWF F8

1.87e-052151230471183
Pubmed

TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin.

NLRC4 TLR5

1.87e-052151221072873
Pubmed

Contributions of Asn2198, Met2199, and Phe2200 in the factor VIII C2 domain to cofactor activity, phospholipid-binding, and von Willebrand factor-binding.

VWF F8

1.87e-052151212719775
Pubmed

The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.

VWF F8

1.87e-052151230642920
Pubmed

Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.

VWF F8

1.87e-052151216823491
Pubmed

Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.

CLCNKA CLCNKB

1.87e-052151224863058
Pubmed

The D' domain of von Willebrand factor requires the presence of the D3 domain for optimal factor VIII binding.

VWF F8

1.87e-052151230111575
Pubmed

Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.

CLCNKA CLCNKB

1.87e-05215129916798
Pubmed

Kidney kinetics and chloride ion pumps.

CLCNKA CLCNKB

1.87e-05215129916791
Pubmed

Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome.

ATG7 LAMP2

1.87e-052151233891876
Pubmed

Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells.

VWF F8

1.87e-052151235950488
Pubmed

Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

NLRC4 TLR5

1.87e-052151225914934
Pubmed

Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.

VWF F8

1.87e-052151237726033
Pubmed

A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function.

VWF F8

1.87e-052151222855607
Pubmed

Sources of variation in factor VIII, von Willebrand factor and fibrinogen measurements: implications for detecting deficiencies and increased plasma levels.

VWF F8

1.87e-052151220627205
Pubmed

Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.

VWF F8

1.87e-052151225780857
Pubmed

Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.

VWF F8

1.87e-052151225779970
Pubmed

Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.

VWF F8

1.87e-052151227749002
Pubmed

von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.

VWF F8

1.87e-052151217119108
Pubmed

Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.

VWF F8

1.87e-052151217786534
Pubmed

Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.

VWF F8

1.87e-052151228581694
Pubmed

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.

ASXL1 JAK2

1.87e-052151236005555
Pubmed

Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.

JAK2 PKD1

1.87e-052151230872773
Cytoband1p22.2

GBP4 GBP5 HFM1

1.08e-042815131p22.2
GeneFamilyATP binding cassette subfamily A

ABCA13 ABCA8 ABCA5

7.19e-05141083805
GeneFamilyMyocyte enhancer factor 2 proteins|MADS box family

MEF2A MEF2C

2.10e-0441082649
GeneFamilyRing finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex

FANCM BRCA2 FANCI

2.19e-04201083548
GeneFamilyMyocyte enhancer factor 2 proteins|MADS box family

MEF2A MEF2C

3.49e-04510821086
GeneFamilyChloride voltage-gated channels

CLCNKA CLCNKB

1.54e-03101082302
GeneFamilyX-linked mental retardation|RNA helicases

FANCM HFM1

1.88e-031110821168
GeneFamilyLaminin subunits

LAMA3 LAMC1

2.24e-03121082626
GeneFamilyWD repeat domain containing|GRAM domain containing|BEACH domain containing

TBC1D9 GRAMD2A

2.64e-031310821146
GeneFamilyAnaphase promoting complex |Tetratricopeptide repeat domain containing

ANAPC1 CDC27

3.07e-03141082402
GeneFamilyOlfactory receptors, family 8

OR8H2 OR8H3 OR8D1

3.13e-03491083155
GeneFamilyCD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing

TICAM1 IL17RD

3.53e-031510821296
GeneFamilyAminopeptidases|CD molecules

LVRN XPNPEP2

4.53e-03171082104
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

TTC28 RGPD1 TTC27 CDC27

5.01e-031151084769
GeneFamilyLipases|Arylacetamide deacetylase family

DAGLB LIPF

7.55e-03221082464
CoexpressionAtlasB cells, B1a.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-3

DMXL2 MPEG1 LAMC1 PKD1L3 MEF2C NLRC4 TBC1D9 GRAMD2A GBP4 SORCS2 KYNU

1.22e-0532514211GSM538222_500
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MGAM COL12A1 ABCA13 PCLO APOB TEX11 XIRP2 UNC13C ATP1A4 UNC79 ANO3

3.87e-11184151112cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MGAM COL12A1 ABCA13 PCLO APOB TEX11 XIRP2 UNC13C ATP1A4 UNC79 ANO3

3.87e-11184151112b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MGAM COL12A1 ABCA13 PCLO APOB TEX11 XIRP2 UNC13C ATP1A4 UNC79 ANO3

3.87e-1118415111ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCLO TBC1D9 NEGR1 UNC13C UNC79 ANO3 CDH12 CNR1

1.92e-071801518f6a2208960d0df1500c974cc44c3c054cd7475a9
ToppCellfacs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STARD8 SLC44A2 LAMA3 MEF2A F8 MEF2C HSD3B1 NOSTRIN

3.53e-0719515183969b8d5fcec8ef1831531a781f7bbcebab5a4ba
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF ITGA8 F8 MEF2C GBP4 DCHS1 NOSTRIN

4.11e-0719915188b62d43af8b2ebb4c1b2d068d50beaf35728dbe7
ToppCellfacs-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPEG1 MEF2C TBC1D9 GRAMD2A NOSTRIN KYNU TCTN1

1.75e-061681517d2afc097ae1243574210be6a751685f949ea941a
ToppCellfacs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPEG1 MEF2C TBC1D9 GRAMD2A NOSTRIN KYNU TCTN1

1.75e-061681517d72cd8238fa793bb3e4add4c59eaaaadcea9930d
ToppCellfacs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MPEG1 MEF2C TBC1D9 GRAMD2A NOSTRIN KYNU TCTN1

1.75e-061681517c34c52165485f612add7a3e35a175d5a6e365e7c
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TBXAS1 DMXL2 RADX MPEG1 TBC1D9 RRAGC KYNU

2.39e-061761517270d7908dbd84028958d257f94941dc685e20255
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF ITGA8 F8 MEF2C DCHS1 NOSTRIN

2.67e-0617915178f9e538c822940785130297712b75131812a4603
ToppCelldroplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 MEF2A F8 MEF2C IGSF10 GBP4 GVINP1

2.77e-061801517dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCelldroplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TTC28 MEF2A F8 MEF2C IGSF10 GBP4 GVINP1

2.77e-061801517423454e3390080ae03bb3cbb267255ebfe4df080
ToppCellAT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

COL12A1 PCLO LMTK2 LAMA3 ABCA8 GRAMD2A THNSL2

3.09e-0618315176821dca076318115d360ff426eb1218cfe104063
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBC1D9 NEGR1 UNC13C UNC79 ANO3 CDH12 CNR1

3.57e-0618715177b2cd0c618ed081223343f3bec2244c8723c9a31
ToppCellCOVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE2A SLC44A2 ITGA8 SHROOM2 F8 MEF2C NOSTRIN

4.54e-061941517660535b492445063d965095a50e1e299ce04c50a
ToppCellChildren_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

HEXB TBXAS1 DMXL2 ATG7 ZFYVE16 ADAM17 KYNU

4.70e-0619515179d649ac7d2af313481069c95349efc0c68449e2b
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SFTA2 COL12A1 LAMA3 GRAMD2A SPRING1 PLXNA1 SCAI

4.70e-0619515172a1863f4b9fe73c30b0b1acf9b12fc98ef65040f
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LVRN COL12A1 LAMC1 ATP8B2 ABCA8 IGSF10 NEGR1

4.70e-061951517f54bc4454270ff06e85596f98199372b50d0179f
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SFTA2 COL12A1 LAMA3 GRAMD2A SPRING1 PLXNA1 SCAI

4.70e-06195151768f4cc84b5ae7f4159b780c78e4b66c94211779a
ToppCellMid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PCLO MEF2C ABCA5 NEGR1 PKD1 UNC79 SCAI

4.86e-061961517676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCellTracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PDE2A VWF STARD8 GBP4 HFM1 NOSTRIN CNR1

5.02e-061971517a78111171819db746af7b162c77f9a324453f3ce
ToppCelldistal-Endothelial-Bronchial_Vessel_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PDE2A VWF LAMC1 MEF2C XIRP2 NOSTRIN IL17RD

5.19e-0619815175bdffabf80716dd80c1265c3d126c7a25340251c
ToppCellSomatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HIVEP2 PCLO MEF2C ABCA5 NEGR1 PKD1 UNC79

5.19e-061981517c01091ef18e096d792ea2a7a715764a5b215355f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF ITGA8 F8 MEF2C GBP4 NOSTRIN

5.19e-0619815171378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HIVEP2 PCLO MEF2C NEGR1 UNC79 CDH12 SCAI

5.19e-0619815178ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCellKidney-Endothelial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.

PDE2A VWF F8 MEF2C GBP4 DCHS1 NOSTRIN

5.37e-061991517b543f0686522df43737e9ffa5c9733e42b8a9f4d
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type.

DPYSL3 HIVEP2 SPAST TTC28 PCLO MEF2C CRMP1

5.55e-06200151784e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF F8 MEF2C GBP4 DCHS1 NOSTRIN

5.55e-062001517b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCellNeuronal|World / cells hierarchy compared to all cells using T-Statistic

PCLO MEF2C ABCA5 NEGR1 PKD1 UNC79 SCAI

5.55e-06200151748d801219bc771d6c7e151dc88ca4c179988de85
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF F8 MEF2C GBP4 DCHS1 NOSTRIN

5.55e-062001517dba96cda5f3b780a3d4171b61bc8aaddc1f5d466
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF F8 MEF2C GBP4 DCHS1 NOSTRIN

5.55e-062001517ced14d83222dbebca85c40540e76824e683354f3
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF F8 MEF2C GBP4 DCHS1 NOSTRIN

5.55e-0620015177a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HIVEP2 RGPD1 ATP8B2 RESF1 GBP5 CCR7

1.39e-0515315167480522a47e367f8facc4f5d599fbaf0b5ad4007
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

HIVEP2 RGPD1 ATP8B2 RESF1 GBP5 CCR7

1.55e-05156151653ded973358e3e48054130131e959f0d1f4ef60f
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

VWF LAMA3 GBP4 GVINP1 CLCNKB

1.63e-05931515312291db0fab96952017f9faf2057c28f3719556
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

VWF LAMA3 GBP4 GVINP1 CLCNKB

1.63e-059315154eca07c288fe15531a685522c61746671c1c87fb
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

VWF LAMA3 GBP4 GVINP1 CLCNKB

1.63e-059315158f65381291fc92b56bf0fc2caac013a54560737b
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9

PDE2A ITGA8 XPNPEP2 ABCA8 IGSF10 NEGR1

1.79e-0516015168a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9

PDE2A ITGA8 XPNPEP2 ABCA8 IGSF10 NEGR1

1.79e-051601516c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCellCOVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type

PDE2A VWF ITGA8 F8 MEF2C NOSTRIN

1.79e-0516015160d4880f85565d8c540c94a8f8109147b3029279a
ToppCellTCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9

PDE2A ITGA8 XPNPEP2 ABCA8 IGSF10 NEGR1

1.79e-051601516d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EEF1AKMT4-ECE2 COL12A1 ABCA8 GPR161 NEGR1 ANO3

1.99e-0516315168e32b6431e1862572663aa6ddc4ea299c6acc8a6
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EEF1AKMT4-ECE2 COL12A1 ABCA8 GPR161 NEGR1 ANO3

1.99e-051631516bbc078761c5043af13d9a6fcf3145a3e300bae5e
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass

GBP4 GBP5 XIRP2 LRRTM2 CFAP74 ANO3

2.06e-051641516362c16ed7fb37bf16601fd5e059d3f3e2ed692b4
ToppCellfacs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYF5 ABCA13 MPEG1 NEGR1 KYNU TCTN1

2.21e-051661516a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCellfacs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYF5 ABCA13 MPEG1 NEGR1 KYNU TCTN1

2.21e-0516615160f641302a6b71c4badaaf20f51162bfc2386b167
ToppCellPND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DMXL2 RADX MPEG1 TBC1D9 UNC13C KYNU

2.36e-051681516a1755afa2cc50960ba60e07d84d61be429cdea72
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF MEF2C GVINP1 DCHS1 NOSTRIN

2.36e-05168151637249f38f8f04ec5743097259de67b106ca2b02f
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

COL12A1 XPNPEP2 ITIH2 FANCI KYNU

2.55e-0510215150bbc6344d0baee47326a16a89773bb5c68a7b040
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

COL12A1 XPNPEP2 ITIH2 FANCI KYNU

2.55e-05102151511fbdb428824023603e9d4ee41e957ba84e7c29e
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LVRN COL12A1 LAMC1 ATP8B2 ABCA8 ADH4

2.69e-051721516e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCellE18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEXB TBXAS1 STARD8 MPEG1 MEF2C GBP5

2.69e-051721516c96bd3407911df3e3e6d7a3dba786b11814b9598
ToppCellAT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

SFTA2 COL12A1 LAMA3 ABCA8 SPRING1 PLXNA1

2.78e-0517315163afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DPYSL3 TTC27 ABCA8 NEGR1 ATP1A4 CNR1

2.78e-051731516ab6d3507301038f944ad59ccd848b5e6eeb76d04
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DAGLB HEXB TBXAS1 MPEG1 MEF2C NLRC4

2.97e-05175151653e6f1f8dd482dfa2539e068dacefbb6e08443bc
ToppCellfacs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWF SHROOM2 TLR5 SORCS2 HFM1 IL17RD

3.06e-0517615167292e014b8f697f0c2e9f47c48333de95cb44a69
ToppCellPND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TBXAS1 DMXL2 LIPF MPEG1 TBC1D9 RRAGC

3.06e-051761516b0b87eebcf5c994386b39ca607e17f10e9d9de74
ToppCellfacs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWF SHROOM2 TLR5 SORCS2 HFM1 IL17RD

3.06e-05176151688ca2f83d8301633232735f39b0683efe49d0b86
ToppCellPND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEXB TBXAS1 STARD8 MATN1 MEF2C NLRC4

3.37e-051791516fae869fb0a91428481bf8a9c111dcc639e2b4278
ToppCellAT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

COL12A1 LAMA3 ABCA8 GRAMD2A PLXNA1 SCAI

3.37e-0517915161603117b52623663458a977c94bf7f9f6c1114b8
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DAGLB HEXB TBXAS1 MPEG1 MEF2C NLRC4

3.48e-051801516a600bc705993d3a010550a25d3b54358946f061f
ToppCelldroplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DPYSL3 PDE2A TTC28 ITGA8 F8 JAK2

3.58e-051811516fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 DMXL2 RADX LIPF MPEG1 TBC1D9

3.70e-0518215163dec003bad0f3716cf8163861a9d4302a7d6df8c
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

COL12A1 VWF LAMC1 F8 ABCA8 NEGR1

3.70e-051821516fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

DPYSL3 ZFYVE16 MLYCD ARMH3 KYNU SCAI

3.81e-051831516310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e
ToppCellCOVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type

VWF ITGA8 F8 MEF2C GBP4 NOSTRIN

3.81e-0518315163c4153479fc4ab2d073d92cee120480015555914
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DPYSL3 COL12A1 TEX11 SORCS2 HFM1 MACROH2A2

3.81e-051831516269afec240a756eec3bbae5f30ec784281af3433
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF MSH2 FANCI EXO1 NOSTRIN

3.93e-051841516688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 DMXL2 RADX LIPF MPEG1 TBC1D9

4.05e-051851516775b72319ef6acffd2c9a74293b9c1bccea33f42
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBXAS1 DMXL2 RADX LIPF MPEG1 TBC1D9

4.05e-051851516afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SMG1 LAMC1 TIPARP SERPINB5 GBP5 USP47

4.05e-051851516eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TBC1D9 CRMP1 NEGR1 UNC79 CDH12 CNR1

4.17e-051861516d6c8ce2a32c218dcc63d861cc247152430ed3c8c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CASR TBC1D9 CLCNKA CLCNKB ABCA5 UNC13C

4.43e-051881516eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DPYSL3 COL12A1 ITGA8 ABCA8 NEGR1 ANO3

4.84e-051911516107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DPYSL3 ITGA8 LAMC1 ABCA8 NEGR1 ANO3

4.84e-0519115166688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellEndothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

DPYSL3 PDE2A VWF CASR F8 DCHS1

4.84e-051911516f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL12A1 LAMA3 ABCA8 GRAMD2A SPRING1 SCAI

4.84e-051911516a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DPYSL3 COL12A1 ITGA8 ABCA8 NEGR1 ANO3

4.84e-051911516bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCelldroplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STARD8 ABCA13 PCLO CASR CLCNKA CLCNKB

4.98e-051921516e19e3e8edcc08e4a67873bfb6e46489ca6c8756a
ToppCellrenal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

MGAM COL12A1 ITGA8 SHROOM2 CLCNKA UNC13C

4.98e-0519215166c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DPYSL3 BCHE ABCA8 IGSF10 NEGR1 IL17RD

4.98e-051921516e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCellCOVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE2A TTC28 MEF2A F8 MEF2C NOSTRIN

4.98e-05192151627ff3621e177e7932dd44dd6baa81551ea75a874
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DPYSL3 ITGA8 LAMC1 ABCA8 NEGR1 ANO3

4.98e-05192151699ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

COL12A1 VWF TTC28 LAMC1 ABCA8 NEGR1

4.98e-05192151660b1312e84f6d6448365a952469c506c00b5fe93
ToppCelldroplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STARD8 ABCA13 PCLO CASR CLCNKA CLCNKB

4.98e-05192151661c2caf6c838132ed5faa8791c288f2149eba2c8
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DPYSL3 COL12A1 ABCA8 ADH4 NEGR1 ATP1A4

5.12e-051931516dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DPYSL3 COL12A1 ABCA8 ADH4 NEGR1 ATP1A4

5.12e-051931516e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

COL12A1 ITGA8 LAMC1 BCHE MEF2C SLITRK6

5.12e-051931516e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

COL12A1 ITGA8 LAMC1 BCHE MEF2C SLITRK6

5.12e-051931516b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCellMonocytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id

DMXL2 MPEG1 MEF2C GBP4 GBP5 KYNU

5.27e-051941516fa6a2794baa6be6298f415330ff51b26a5402571
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF ITGA8 F8 MEF2C NOSTRIN

5.27e-051941516f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF ITGA8 F8 MEF2C NOSTRIN

5.27e-051941516a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF ITGA8 F8 MEF2C NOSTRIN

5.27e-051941516f76808666fb875fc787751cbfd924d9be20a8192
ToppCellcontrol-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MPEG1 MEF2A MEF2C TBC1D9 CCR7 KYNU

5.27e-051941516a5284adca931a78b1c4592925c4860853ebd24f1
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A VWF ITGA8 F8 MEF2C NOSTRIN

5.27e-051941516e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCellASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

DPYSL3 VWF F8 GBP4 DCHS1 NOSTRIN

5.43e-051951516304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56
ToppCellnormal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass

SFTA2 COL12A1 LAMA3 GRAMD2A PLXNA1 SCAI

5.43e-051951516569d1ebc5a5aa110a2430b096755ae35354040c4
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

ITGA8 LAMC1 ABCA8 IGSF10 NEGR1 ANO3

5.43e-051951516aa0add081881d349099d12efca5cdee098038d4e
ToppCellCOVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type

PDE2A VWF ITGA8 F8 MEF2C NOSTRIN

5.43e-051951516a436483fec137584611f86b7a498a4dc2aa19cd3
DiseaseBartter disease type 4B

CLCNKA CLCNKB

2.47e-0521472cv:C4310805
Diseasevon Willebrand's disease 2 (is_marker_for)

VWF F8

2.47e-0521472DOID:0060574 (is_marker_for)
DiseaseBartter disease type 3 (implicated_via_orthology)

CLCNKA CLCNKB

2.47e-0521472DOID:0110144 (implicated_via_orthology)
DiseaseBARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS

CLCNKA CLCNKB

2.47e-0521472613090
DiseaseBARTTER SYNDROME, TYPE 4B

CLCNKA CLCNKB

2.47e-0521472C2751312
DiseaseBARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS

CLCNKA CLCNKB

2.47e-0521472C4310805
DiseaseBartter disease type 4b (is_implicated_in)

CLCNKA CLCNKB

2.47e-0521472DOID:0110146 (is_implicated_in)
DiseaseBartter disease (implicated_via_orthology)

CLCNKA CLCNKB

2.47e-0521472DOID:445 (implicated_via_orthology)
DiseaseProstatic Neoplasms

TBXAS1 LMTK2 LAMC1 NIPAL3 JAK2 BRCA2 TLR5 HSD3B1 CDC27 IL17RD CDH12 GOLGA4

6.39e-0561614712C0033578
DiseaseMalignant neoplasm of prostate

TBXAS1 LMTK2 LAMC1 NIPAL3 JAK2 BRCA2 TLR5 HSD3B1 CDC27 IL17RD CDH12 GOLGA4

6.39e-0561614712C0376358
DiseaseBone marrow hypocellularity

FANCM BRCA2 FANCI

9.36e-05181473C1855710
DiseaseLiver Cirrhosis, Experimental

COL12A1 VWF ZFYVE16 SLC44A2 XPNPEP2 TBC1D9 ADH4 JAK2 GBP4 ADAM17 SLC37A4 KYNU CNR1

1.40e-0477414713C0023893
Diseasemyeloproliferative neoplasm (implicated_via_orthology)

ASXL1 JAK2

1.47e-0441472DOID:2226 (implicated_via_orthology)
DiseaseMuscle Spasticity

SPAST CNR1

2.44e-0451472C0026838
DiseaseFanconi Anemia

FANCM BRCA2 FANCI

2.57e-04251473C0015625
DiseasePancytopenia

FANCM BRCA2 FANCI

2.90e-04261473C0030312
DiseaseMalignant neoplasm of breast

TBXAS1 PDE2A VWF STARD8 SPAST NOA1 TICAM1 BCHE SHROOM2 EEF2 SERPINB5 BRCA2 EXO1 CDC27 ZNF281

3.17e-04107414715C0006142
DiseaseGrand Mal Status Epilepticus

LAMP2 MEF2C CCR7 CNR1

3.55e-04671474C0311335
DiseaseStatus Epilepticus, Subclinical

LAMP2 MEF2C CCR7 CNR1

3.55e-04671474C0751522
DiseaseSimple Partial Status Epilepticus

LAMP2 MEF2C CCR7 CNR1

3.55e-04671474C0751524
DiseaseNon-Convulsive Status Epilepticus

LAMP2 MEF2C CCR7 CNR1

3.55e-04671474C0751523
DiseaseMYELODYSPLASTIC SYNDROME

ASXL1 FANCM BRCA2 FANCI

3.55e-04671474C3463824
DiseasePetit mal status

LAMP2 MEF2C CCR7 CNR1

3.55e-04671474C0270823
DiseaseComplex Partial Status Epilepticus

LAMP2 MEF2C CCR7 CNR1

3.55e-04671474C0393734
Diseaseessential thrombocythemia (is_implicated_in)

VWF JAK2

3.65e-0461472DOID:2224 (is_implicated_in)
DiseaseMEDULLOBLASTOMA

GPR161 BRCA2

3.65e-0461472155255
DiseaseBartter syndrome

CLCNKA CLCNKB

3.65e-0461472cv:C0004775
Diseasefamilial combined hyperlipidemia (is_marker_for)

VWF APOB

3.65e-0461472DOID:13809 (is_marker_for)
DiseaseAdult only

MSH2 BRCA2

3.65e-0461472C3842001
DiseaseMedulloblastoma

GPR161 BRCA2

3.65e-0461472cv:C0025149
DiseaseStatus Epilepticus

LAMP2 MEF2C CCR7 CNR1

3.76e-04681474C0038220
DiseaseMiller Dieker syndrome

FANCM BRCA2 FANCI

4.03e-04291473C0265219
Diseaseplatelet-to-lymphocyte ratio

VWF TTC28 LEMD2 MEF2C JAK2 CCR7 NOSTRIN ARMH3

4.91e-043631478EFO_0008446
DiseaseColorectal Neoplasms

STARD8 ABCA13 MSH2 ABCA8 SERPINB5 ABCA5 EXO1

4.96e-042771477C0009404
DiseaseLDL cholesterol change measurement

APOB PKD1L3

5.09e-0471472EFO_0007804
Diseaseintellectual disability (implicated_via_orthology)

HIVEP2 ITGA8 MEF2A MEF2C

5.46e-04751474DOID:1059 (implicated_via_orthology)
Diseaseovarian neoplasm

ATG7 ITGA8 MSH2 TIPARP BRCA2

5.71e-041341475C0919267
Diseaseinterleukin 18 measurement

SPAST TTC27 NLRC4 NOSTRIN

5.74e-04761474EFO_0004581
DiseaseAbnormality of radial ray

FANCM BRCA2 FANCI

5.92e-04331473C4228778
Diseasemean platelet volume

DAGLB HIVEP2 VWF STARD8 TTC28 PCDHGA9 CASR MEF2C ADH4 JAK2 MORF4L2 KYNU FBXO34 NIN

5.99e-04102014714EFO_0004584
DiseaseMalignant neoplasm of ovary

ATG7 ITGA8 MSH2 TIPARP BRCA2

6.32e-041371475C1140680
Diseasemyelofibrosis (is_implicated_in)

ASXL1 JAK2

6.77e-0481472DOID:4971 (is_implicated_in)
Diseasemesangial proliferative glomerulonephritis (biomarker_via_orthology)

VWF ITGA8

6.77e-0481472DOID:4783 (biomarker_via_orthology)
DiseaseGlioma

GPR161 BRCA2

8.67e-0491472cv:C0017638
Diseasevenous thromboembolism, factor VII measurement

VWF SLC44A2 ADH4

8.99e-04381473EFO_0004286, EFO_0004619
Diseasemedulloblastoma (is_implicated_in)

GPR161 BRCA2

1.08e-03101472DOID:0050902 (is_implicated_in)
Diseasenephrogenic diabetes insipidus (implicated_via_orthology)

CLCNKA CLCNKB

1.08e-03101472DOID:12387 (implicated_via_orthology)
Diseasethrombosis (implicated_via_orthology)

TBXAS1 JAK2

1.08e-03101472DOID:0060903 (implicated_via_orthology)
DiseaseFanconi anemia (is_implicated_in)

BRCA2 FANCI

1.08e-03101472DOID:13636 (is_implicated_in)
Diseasecytochrome p450 3a4 measurement

BCHE APOB

1.32e-03111472EFO_0020303
Diseasehyperhomocysteinemia (implicated_via_orthology)

BCHE F8

1.32e-03111472DOID:9279 (implicated_via_orthology)
Diseasenervous system disease (implicated_via_orthology)

ATG7 ATP1A4

1.57e-03121472DOID:863 (implicated_via_orthology)
Disease11beta-hydroxyandrosterone glucuronide measurement

SPAST NLRC4

1.57e-03121472EFO_0800573
Diseaseintegral membrane protein 2B measurement

BCHE APOB

1.57e-03121472EFO_0802634
Diseasedisks large homolog 3 measurement

TEX11 MEF2C

1.57e-03121472EFO_0802472
DiseaseFanconi anemia

BRCA2 FANCI

2.16e-03141472cv:C0015625
DiseaseAlcoholic Intoxication, Chronic

VWF TIPARP ADH4 ANAPC1 CDH12 CNR1

2.31e-032681476C0001973
DiseaseProteinuria

VWF UNC13C

2.48e-03151472HP_0000093
Diseasemyelodysplastic syndrome (implicated_via_orthology)

ASXL1 ATG7

2.48e-03151472DOID:0050908 (implicated_via_orthology)
DiseaseHypertriglyceridemia

BCHE APOB

2.48e-03151472C0020557
Diseaseovarian cancer (is_implicated_in)

ITGA8 APOB BRCA2

2.77e-03561473DOID:2394 (is_implicated_in)
DiseaseColorectal Carcinoma

STARD8 ABCA13 LAMC1 APOB MSH2 ABCA8 SERPINB5 ABCA5 DCHS1 EXO1

2.80e-0370214710C0009402
Diseasevisceral adipose tissue measurement

HIVEP2 LEMD2 PKD1L3 ARMH2 PKD1 THNSL2 SLITRK6 UNC79

2.92e-034811478EFO_0004765
Diseasekeratinocyte carcinoma

TICAM1 BRCA2 EXO1 THNSL2

2.92e-031181474EFO_0010176
Diseaseresponse to efavirenz, virologic response measurement

PIGN IGSF10 SLC37A4

3.06e-03581473EFO_0006904, EFO_0006906
Diseaseneuroimaging measurement, brain volume measurement

EEF1AKMT4-ECE2 RGPD1 LAMC1 NOSTRIN TUBD1 SCAI

3.18e-032861476EFO_0004346, EFO_0006930
Diseasenoggin measurement

HIVEP2 MEF2C

3.58e-03181472EFO_0021995
Diseasehair colour measurement

ASXL1 ZFYVE16 NIPAL3 PKD1L3 GPR161 FOLH1B UNC13C THNSL2 PLXNA1

3.80e-036151479EFO_0007822
Diseaseurate measurement, bone density

DPYSL3 TTC28 ABCA8 TIPARP GBP4 GBP5 A2ML1 CDH12 PDZD2

3.96e-036191479EFO_0003923, EFO_0004531
DiseaseX-11470 measurement

SPAST TTC27

3.99e-03191472EFO_0021241
Diseasehippuric acid measurement

A2ML1 CDH12

3.99e-03191472EFO_0010496
Diseasechemerin measurement

ATG7 UNC13C

3.99e-03191472EFO_0004573
Diseasesodium-coupled monocarboxylate transporter 1 measurement

BCHE APOB

3.99e-03191472EFO_0802076
DiseaseColorectal cancer, hereditary nonpolyposis, type 1

MSH2 EXO1

3.99e-03191472C2936783
Diseaseage at menopause

MGAM TTC28 FANCM TIPARP FANCI EXO1

4.15e-033021476EFO_0004704
Diseaseverbal-numerical reasoning measurement

DMXL2 MEF2C NEGR1 ARMH3

4.25e-031311474EFO_0008394
Diseasebody weight

MGAM HIVEP2 NBEAL1 RGPD1 SLC44A2 TEX11 ACYP2 NEGR1 PKD1 FOLH1B TRIM13 UNC79 PLXNA1 PDZD2

4.27e-03126114714EFO_0004338
Diseaseanti-Mullerian hormone measurement

TTC28 MEF2C

4.42e-03201472EFO_0004769
Diseaseatherosclerosis (biomarker_via_orthology)

CASR JAK2

4.42e-03201472DOID:1936 (biomarker_via_orthology)
DiseaseDeep Vein Thrombosis

F8 JAK2

4.86e-03211472C0149871
DiseaseVenous Thrombosis

F8 JAK2

4.86e-03211472C0042487
Diseasevenous thromboembolism, plasminogen activator inhibitor 1 measurement

VWF SLC44A2

4.86e-03211472EFO_0004286, EFO_0004792
DiseaseOvarian Failure, Premature

XPNPEP2 HFM1

4.86e-03211472C0085215

Protein segments in the cluster

PeptideGeneStartEntry
NASRQESFSSILAYK

ABCA5

1556

Q8WWZ7
FSNEKTISKLEYSNF

ACYP2

81

P14621
EDNGLKNSTFTYFTS

ARSD

341

P51689
FKSTEQKYLTLNTES

BCHE

521

P06276
TLSNSVFTFSYKKAQ

HSD3B1

321

P14060
TFSQYTVVSDINLAK

ADH4

151

P08319
FESTIKSETNSYLLL

ARMH2

156

H3BNL8
SYASSSRLLSNKNQF

CASR

166

P41180
LAAVTVKLYSSFDFN

CALHM3

26

Q86XJ0
VAVTSTNAAKIFNLY

DPYSL3

381

Q14195
NFLKDSYTALTSITA

GVINP1

491

Q7Z2Y8
SCFLNYLQKTEQTDT

GVINP1

676

Q7Z2Y8
STQKRYTFTNTFIID

GVINP1

2016

Q7Z2Y8
SSASSLKNVYFLLFD

MACROH2A2

341

Q9P0M6
LSDYSQLNESTTKES

FBXO34

491

Q9NWN3
DELIKNTQTYTFTIS

A2ML1

1406

A8K2U0
NTTVDYTLFESLCSK

CCR7

36

P32248
IYFNILENNSSSKTE

ABCA13

1561

Q86UQ4
DVQTSNLLITFLKYS

ARMH3

361

Q5T2E6
YFAVSNSDLSSVKLL

ASB14

361

A6NK59
EFETSSTYISILNQK

DMXL2

1761

Q8TDJ6
TSEIQELFDIFTYSK

LVRN

491

Q6Q4G3
KLDDISSNYTESFST

DMXL1

1996

Q9Y485
KLQLSSTSFNYSSSS

ASXL1

1446

Q8IXJ9
YSKSLSQSTSLFQST

ANO3

46

Q9BYT9
IQAVLASDYSFSQFK

ATP8B2

856

P98198
TSTILENYFKLLNSD

NBEAL1

291

Q6ZS30
INLETLQSAFYTEKF

JAK2

256

O60674
ENSFTIQYILDTSDK

TIPARP

191

Q7Z3E1
EKFSLSQESSYIATQ

LBR

151

Q14739
TSYSINTELSLFSKV

MPEG1

111

Q2M385
NSLDQEKVSSVFYTT

OR8D1

266

Q8WZ84
SYNESETKSTLLFGQ

KIF5B

306

P33176
NASFTYLTALTDSNI

LRWD1

626

Q9UFC0
RFTSKYVSSVLSFQE

LTN1

1596

O94822
YFQTTSTNLSLSNKI

RADX

611

Q6NSI4
FIISQDKSEKAYSSN

ANAPC1

131

Q9H1A4
EYSSISEKLSSTNFA

C8orf76

76

Q96K31
EVLIEYNFSISSFSK

FANCI

751

Q9NVI1
TYSLQQLSEDSKAFR

DCHS1

1141

Q96JQ0
KTLANLLTSNYISFT

OR8H2

81

Q8N162
SNVYATDKNSLSSLD

MYF5

191

P13349
LSSNKIFYLPNTTFT

LRRTM2

116

O43300
SAVSEASFSYKENLI

NIPAL3

21

Q6P499
QSSSAALSKFIAVYF

IL17RD

466

Q8NFM7
AALKYLIDNSFTVSS

MATN1

356

P21941
LQSDFTKYLTTADSS

LAMA3

2076

Q16787
VLTLSSFTSIFYLKN

NEGR1

336

Q7Z3B1
LYQESTSKSALSQEF

NLRC4

561

Q9NPP4
DTSSQLKKFYNQVST

ITIH2

481

P19823
QEYIANVTSSSSAKF

LEMD2

306

Q8NC56
ASAKLDVFQSYQSAT

GOLGA4

796

Q13439
TADISLKSSVYANAF

MGAM

1016

O43451
NLYNTLDSSITDKSE

KIAA1109

4531

Q2LD37
ALNSTFDYSEFSLEK

FANCM

1376

Q8IYD8
NKITAAIFYSISLTQ

MLYCD

281

O95822
DSKNFNTSRLDVYLS

LIPF

266

P07098
SSSNFDESLNSLKYA

KIF27

321

Q86VH2
SAESSQKKTSLYFDE

PCLO

1681

Q9Y6V0
SAYNISNSSTFTKSL

PLXNA1

1606

Q9UIW2
QTYSQEFSLTADSRK

PCDHGA9

751

Q9Y5G4
KDSLISESELSQYFA

PDZD2

856

O15018
SFQVASKSVLAALYS

PDE2A

706

O00408
FQLESTFDLKRYLSS

HMX1

216

Q9NP08
TYSLSFDSLFSAVKN

FOLH1B

316

Q9HBA9
NSASLFTASDYKVAS

MORF4L2

266

Q15014
NFTKAASTYSIDSVS

LAMP2

101

P13473
SFQDRLLTADQTKYS

LMTK2

316

Q8IWU2
YSSTLKFQAGFLNTT

LYPD4

171

Q6UWN0
IIFNSTNKLFQYAST

MEF2C

46

Q06413
LLSSSFVYNSVSTIN

GBP4

136

Q96PP9
LLSSTFVYNTVNKID

GBP5

121

Q96PP8
SKAISDAQITASSYF

F8

2201

P00451
IIFNSSNKLFQYAST

MEF2A

46

Q02078
NISLNYSLDESTFKE

ITGA8

601

P53708
KTLANLLTSNYISFT

OR8H3

81

Q8N146
LAYLSFADISSISNS

OR1S2

76

Q8NGQ3
ITNEDTNYISLTQKF

HFM1

76

A2PYH4
SSNQTEFKFDLTLNY

HFM1

501

A2PYH4
FITSSQSAAYAISKF

SLC37A4

51

O43826
FTVYISADSKSSNSN

EEF1AKMT4-ECE2

351

P0DPD8
NITYDFSFKSSVITL

APOB

3336

P04114
DTFVSLSYLQIFKIS

IGSF10

171

Q6WRI0
TLYNTNTLESFKTAD

ATG7

86

O95352
VEYSDTDFQSQKSLL

BRCA2

746

P51587
ETSTSLKDLFSQTLY

COL12A1

1616

Q99715
LKDLFSQTLYTVSVS

COL12A1

1621

Q99715
FFYAISSSKSSNVIV

GPR89A

366

B7ZAQ6
FFYAISSSKSSNVIV

GPR89B

366

P0CG08
SKALQEYSQSFIVSL

DAGLB

476

Q8NCG7
SQFSLEKYLSQEEQS

HAUS3

196

Q68CZ6
VNITEFYNKSLSSFK

CNR1

76

P21554
SYLLTLSNKFVFSLT

GPR161

56

Q8N6U8
AKTANDTSTEAYNLL

LAMC1

1201

P11047
TAVFLSTSNEAVYKI

SLC44A2

381

Q8IWA5
STAQYNFSIIASKVS

CDH12

451

P55289
KSTAISLFYELSEND

EEF2

71

P13639
TTNTSQKYIFVSLLS

GRAMD2A

151

Q8IUY3
LNTTYSFLTTFFKEI

HEXB

326

P07686
NLESSNSKYSLNTDS

CDC27

216

P30260
NSKYSLNTDSSVSYI

CDC27

221

P30260
FTNSKLTSLNEEYTK

MSH2

551

P43246
KSLYDKAATSFSEQQ

CFAP74

681

Q9C0B2
VAVTSTNAAKIFNLY

CRMP1

381

Q14194
KSTLFNTLLESDYCT

NOA1

351

Q8NC60
YQSAAVFKLSLTASN

PKD1

986

P98161
SFAKDTVLTYLTNFS

OR2B2

321

Q9GZK3
VLYNALFSSQSSKDT

RGPD1

376

P0DJD0
LSTENKSEFLLTDYF

NOSTRIN

271

Q8IVI9
SLVYFLSSTFKQEER

SPRING1

26

Q9H741
TNKIYKDDISNSSFV

RRAGC

96

Q9HB90
KYKTTNQSTEFLSFQ

SLITRK6

736

Q9H5Y7
SDFQQKISSVLSYNE

NIN

1696

Q8N4C6
GDTSYNSQIAKIFSS

RESF1

901

Q9HCM1
TDTQLVSFQSALLYT

SEC24A

796

O95486
STSSTSLNLKADFNY

SMG1

1216

Q96Q15
SLTVQDDYIFFKATS

SORCS2

346

Q96PQ0
FTALYSLELSKDQAT

PKD1L3

1171

Q7Z443
QIKTLSTSEQFYSRF

SHROOM2

1246

Q13796
SLSCTTQFLQYFLEK

THNSL2

116

Q86YJ6
QTVTSDVNKLSSFYS

SERPINB5

71

P36952
TQTTQLSLSFKLDYF

MT-ND5

71

P03915
SFNLEASLSKFSYID

VPS8

26

Q8N3P4
ATFFNISAASLTSKY

SPAST

401

Q9UBP0
SEDDLLSQYSLSFTK

EXO1

426

Q9UQ84
FTSKLTTTFLQIYQL

STARD8

656

Q92502
VKQSFDLEEYSLSQS

ABCA8

1571

O94911
LYLTSSTERFSQNFK

ADAM17

81

P78536
ESALLKFIEQSYSSV

ATP1A4

461

Q13733
FNSEQETITSLYKTS

CLCNKA

256

P51800
FNSEQETITSLYKTS

CLCNKB

256

P51801
RYKFENQSLDSISSS

XIRP2

1026

A4UGR9
FSKYEKSAVLVSNSQ

TUBD1

386

Q9UJT1
ITNTLSFATYLLATN

TBXAS1

346

P24557
LSNFSSYLTKTADFI

TRIM13

351

O60858
SYLTKTADFIEQSVF

TRIM13

356

O60858
KVLLQYAAIVSSDFS

UNC13C

1771

Q8NB66
STSEVLKYTLFQIFS

VWF

1356

P04275
LESSSEQKFYNFVIL

TICAM1

386

Q8IUC6
TAFSNYSATLKSQLS

TRIM75

221

A6NK02
SDFLQQTTSKIYSDK

TBC1D9

396

Q6ZT07
TLNAESYVSFTTKLD

TCTN1

186

Q2MV58
SQSYSYSSILNKSET

USP47

171

Q96K76
YLQQAFEKSTNASFT

ZNF281

671

Q9Y2X9
IIVDSSNSVAYKNFT

SCAI

431

Q8N9R8
FLNHLTSFKESYETQ

TEX11

896

Q8IYF3
KLTSIQFSYNTDITQ

PIGN

761

O95427
LSTDYKLSLFDLQTS

TTC28

1156

Q96AY4
KESFLTNSSYESSFL

SFTA2

31

Q6UW10
TNSSYESSFLELLEK

SFTA2

36

Q6UW10
SFSSLYKATFDNVTS

WDR4

356

P57081
LNSFTSSQVKEYLQS

TEX26

251

Q8N6G2
FANKSRFSSETLSYL

XPNPEP2

276

O43895
KTLSFFSLAANSLYS

TLR5

196

O60602
FNSTTTAEEKIDSYL

TTC27

56

Q6P3X3
TEYQRLFQSKSTDSE

HIVEP2

1996

P31629
SVSSLLLFNTTENLY

WASH6P

151

Q9NQA3
FLTEQYLQTTNIKSF

ZFYVE16

536

Q7Z3T8
LKDQDLSILSTSYQF

ZFYVE16

1436

Q7Z3T8
LSILSTSYQFAKEIA

ZFYVE16

1441

Q7Z3T8
SGTDIANTLKYFSQT

UNC79

31

Q9P2D8
DVYKFTNLLTSILDS

KYNU

446

Q16719